The Crohn’s & Colitis Foundation is the only nonprofit organization dedicated to finding cures for inflammatory bowel disease while directly serving millions of people living with IBD annually through essential education, support, and advocacy. We have played a role in every major research breakthrough in IBD. Find out more about our impact.

Across the country, people join our events like Take Steps and Team Challenge to connect with others, find strength in community, and raise vital funds for research, education, and advocacy for everyone impacted by Crohn’s disease and ulcerative colitis.

Support by individuals and Foundations powers cutting-edge research, essential education, and compassionate support programs, helping the Crohn’s & Colitis Foundation drive faster progress toward cures and improve quality of life for everyone affected by IBD.​
“I found a deep gratitude in being surrounded by my people—my community, my fellow IBD patients, and the doctors and other clinicians who speak the same language.” - Ian Goldstein

The Crohn's & Colitis Foundation advances our mission to find cures for IBD and improve patients’ quality of life with the help of committed corporate supporters who provide event sponsorship, program partnership, and cause campaigns. Their support fuels research, education, and support programs for everyone affected by Crohn’s disease and ulcerative colitis.

Revenue from grants and other sources help us support our communities and advance innovative initiatives, including a five-year CDC-funded partnership with the University of Alabama at Birmingham to reduce care barriers for Black/African American IBD patients and improve awareness, diagnosis, and access.

Our 31 local chapters support and connect people with IBD through local educational programs, support groups, walks, fundraising galas, and more. Our national and local board members are vital to our impact offering strategic guidance, championing our mission in their communities, and helping to raise critical awareness and funds that advance our research and patient programs.